Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law […]
Last week’s conferences in Asia Read More »
by Dennis Crouch In a pair of significant decisions issued today, the Federal Circuit upheld preliminary injunctions blocking the launch of biosimilar versions of Regeneron’s blockbuster drug EYLEA® (aflibercept). Regeneron Pharms., Inc. v. Mylan Pharms. Inc., No. 2024-1965 (Fed. Cir. Jan. 29, 2025) (precedential); and Regeneron Pharms., Inc. v. Mylan Pharms. Inc., No. 2024-2009 (Fed.
Biologics Patent Enforcement: Regeneron Patents Block Biosimilar Entry for EYLEA Read More »
As we previously reported, on December 19, 2024, the Patented Medicine Prices Review Board (PMPRB) released its Draft Guidelines for PMPRB Staff regarding Administrative Process for Excessive Price Hearing Recommendation (Draft Guidelines), together with a Simplified Overview. The general review processes contemplated by the Draft Guidelines have been discussed previously in our summary of the
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »
Continue reading this post on Patently-O. Source link
Discussions of Inequitable Conduct in CAFC Decisions Read More »
By Brian Dowling ( January 29, 2025, 3:15 PM EST) — A Massachusetts state judge ruled Wednesday that a forum selection clause can’t protect Uber from answering claims that it stole a Boston technology company’s trade secrets after partnering with it on rider safety pilot projects in Brazil…. Law360 is on it, so you are,
Uber Can’t Duck Mass. Tech Company’s Trade Secrets Suit Read More »
As we previously reported, JAMP sought leave to commence an application against Janssen under the abuse of dominance provisions of the Competition Act (the Act), relating to ustekinumab (Janssen’s STELARA and FINLIUS). This was the first application for leave to commence a proceeding under section 79 of the Act. On November 20, 2024, the Competition
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »
[co-author: Laëtitia Arraul, Sean Kelly, Cindy Mikul, Maria Rozylo, Tony Vitali, Grace Wilshaw] This is the January 2025 edition of Anchovy News. Here you will find articles concerning ICANN, the domain name industry and the recuperation of domain names across the globe. In this issue we cover: Domain name industry news To renew, or not
Domain Name News: January 2025 | Hogan Lovells Read More »
Last week I gave two presentations in Asia. On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R. The presentation summarized some of my current book project, Wrongful Patent Assertion: A Comparative Law
Last week’s conferences in Asia Read More »